4th Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for NORTHWEST KIDNEY CENTERS

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

End-stage renal disease (ESRD) Medicare reimbursement and payment reform. ESRD quality measurement. Improved policies for chronic kidney disease and transplantation. Medicare Third Party Payment. Living Donor Protection Act (H.R. 1270). H.R. 2644, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017. The Dialysis PATIENTS Demonstration Act (H.R. 4143/S. 2065). Kidney X funding.

LobbyistCovered position, as disclosed
KELLY L. DELMORE Legislative Assistant; Office of Phil English

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1270 (115th), H.R. 2644 (115th), H.R. 4143 (115th), S. 2065 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.